Industry News

China State Council’s new directive herald key changes for Chinese R&D

In a surprise move, the State Council in China has recently released a directive announcing its view on reforming the drug and medical device review and approval process in China. The State Council oversees the Chinese Food and Drug Administration (CFDA), and it is noteworthy that these changes were announced at a high level, reflecting […]

Read More

September 1st, 2015

George Clinical In China Celebrates Two Years As An Independent CRO

George Clinical in China recently celebrated its second anniversary as an independent entity in China. Although George Clinical has been conducting Phase 11 to Phase IV studies in China for over 8 years, previously it was incorporated into The George Institute in China – but now operates as a separate legal entity. The last two […]

Read More

August 26th, 2015

CFDA dramatically increase registration fees for drug and clinical trials

China is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from clinicaltrials.gov indicated that in 2014, China had conducted 846 clinical trials, and an […]

Read More

August 1st, 2015

Therapeutic Goods Administration Releases New Online Form for Clinical Trial Notification (CTN) Scheme

The Therapeutic Goods Administration (TGA) has released a new online form for the clinical trial notification (CTN) scheme. When a clinical trial is investigating the use of a product within Australia, which is not on the Australian Register of Therapeutic Goods (ARTG), or on the ARTG yet being used outside its marketing approval conditions, these […]

Read More

July 7th, 2015

Sulfagenix Inc. leverages the R&D Tax Incentive in Australia

Sulfagenix, Inc., a United States based biotech, was able to tap into Australia’s world class research and development (R&D) facilities and expertise

Read More

April 24th, 2015

Hong Kong regulatory process for clinical trials has been revised

New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country

Read More

March 23rd, 2015

New Horizons in India

The Central Drugs Standard Control Organization (CDSCO), India’s regulatory agency for clinical research, has made a series of announcements and corrections

Read More

July 22nd, 2014
People applauding at a conference

See you at ACC.14

From March 29th to 31st, the annual scientific congress for the American College of Cardiology (ACC) will be held at Washington, DC. Thought leaders congregate to discuss prevention, diagnosis and treatment of cardiovascular disease. This year, George Clinical will be represented by Professor Bruce Neal and Professor Henry Krum. See you there!

Read More

March 26th, 2014

FoodSwitch wins

FoodSwitch, a leading health app, has just been awarded “Most Valuable HCP or Health Care Initiative Award” at the eyeforpharma conference in Barcelona

Read More

March 19th, 2014
Woman scanning a barcode with a smart phone

Foodswitch nominated for award

Packaged foods can often be high in salt, fat and sugar where excessive consumption can lead to development of chronic diseases. Foodswitch is an app created by The George Institute to see what’s in the food you’re eating and make better food choices when grocery shopping. With the Foodswitch app, users scan a product to […]

Read More

March 12th, 2014

Add George Clinical to your network